(RTTNews.com) - Novavax Inc. (NVAX) said Monday it has formed a new collaboration with CPL Biologicals and the International Centre for Genetic Engineering and Biotechnology to develop a novel malaria vaccine in India.

Novavax said the collaboration will combine the advanced vaccine technology of Novavax with the malaria vaccine research capabilities of International Centre for Genetic Engineering and Biotechnology, or ICGEB, and vaccine manufacturing capability of CPL Biologicals, or CPLB.

The project is being funded by India'sDepartment of Biotechnology Vaccine Grand Challenge Program.

Malaria remains a major public health problem in many regions of the tropical world. Forty percent of the world's population lives in malaria endemic regions of Africa, Asia and Central and South America.

About 210 million cases of malaria are reported each year, leading to around 650,000 deaths, primarily in children less than five years of age.

For comments and feedback: contact editorial@rttnews.com

http://www.rttnews.com

See the original post:
Novavax In Collaboration For New Malaria Vaccine In India

Comments are closed.